This trial is currently underway and will be opening again for more candidates in some locations in due course. I've been provided the info as I tick the boxes. It will open at my unit, Edinburgh Western.
The purpose of the study is to find out if new treatment Modi-1 can be used safely for breast, H&N, ovarian or renal cancer and benefit these types of cancer. Modi-1 is designed to help your immune system attack and destroy cancer cells.
Brief Summary: "The main objectives of this study are to assess the safety, tolerability, immunological activity, and preliminary efficacy of the Modi-1/Modi-1v vaccine, both as monotherapy and in combination with a checkpoint inhibitor (CPI) such as pembrolizumab or nivolumab (where these are standard of care in a non-neoadjuvant setting), in patients with advanced triple negative breast cancer (TNBC), advanced/unresectable human papillomavirus-negative squamous cell carcinoma of the head and neck (SCCHN), high grade serous ovarian carcinoma (HGSOC), or renal cell carcinoma (RCC)."
I'm just sharing as a heads-up, to meet others considering it, or on it. I did a search of the forum and surprisingly didn't find anything.
I have just read the Scancell info on this and it does look interesting. Cancer Research is showing a trial of it for small cell lung cancer, but not yet for other cancers. With PD-1 positive TNBC, my next standard of care would include Pembrolizumab so this is definitely something I will follow with interest.
This is interesting. I don't know if I would be suitable as it has not been mentioned at any of my hospital visits. I am having palliative radiotherapy only for a squamous cell cancer which has spread from my face to my ear. I'll try and find out more about it.
Good luck with your treatment.
That's the hospital I attend, got appointment next month so will ask my oncologist about this new treatment .
I've just started on the trial this week (june 2023). ModiFY Trial Day 1 The update since the injection is that my arm is a right mess!
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2025 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007